ROCO
3224
Market cap79mUSD
Oct 08, Last price
32.30TWD
1D
-0.46%
1Q
-12.82%
Jan 2017
2.34%
IPO
91.01%
Name
MetaTech AP Inc
Chart & performance
P/E
—
P/S
1.67
EPS
—
Div yield, %
—
Shrs. gr., 5y
3.27%
Rev. gr., 5y
-0.79%
Revenues
1.51b
+7.24%
Net income
-104m
L+51.49%
CFO
-205m
L+13.49%
Dividend
Aug 05, 20080.4353 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
MetaTech (AP) Inc., alongside its subsidiaries, engages in a wide array of activities, including the wholesale and retail distribution of electronic products and equipment across Taiwan and international markets. The company also dedicates resources to the biomedical field, encompassing the development and production of advanced cell sheets and cell therapy-related products, in addition to managing other biomedicine-focused operations and selling petri dishes. Furthermore, MetaTech holds interests in the tourism sector. This multifaceted enterprise was established in 1987 and is headquartered in New Taipei City, Taiwan.
Key people
Chairman of the Board · since 2022
Ying-Chen Yang
Chief Executive Officer-Biomedicine Business Division · since 2024
Zongji Chen
Vice Chairman of the Board · since 2021
Mengqing Zhuo
Manager of Finance & Accounting · since 2024
Jun Hua Qiu
Deputy General Manager-Administrative · since 2020
Meng-fan Shen
Head of Finance & Accounting · since 2025
Yi Wen
Corporate Governance Officer · since 2022
Guanling Lai
Director · since 2021
Hong De Tang
General Manager, Director · since 2016
Weilun Weng
Director · since 2022
Ming-Shiang Wu
Director · since 2021
Wen Zhu Wang
Independent Director · since 2015
Shijie Yang
Independent Director · since 2021
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||